ANKS4B

gene
On this page

Also known as FLJ38819HARP

Summary

ANKS4B (ankyrin repeat and sterile alpha motif domain containing 4B, HGNC:26795) is a protein-coding gene on chromosome 16p12.2, encoding Ankyrin repeat and SAM domain-containing protein 4B (Q8N8V4). As part of the intermicrovillar adhesion complex/IMAC plays a role in epithelial brush border differentiation, controlling microvilli organization and length.

Involved in brush border assembly; protein localization to microvillus; and protein-containing complex assembly. Located in brush border and microvillus.

Source: NCBI Gene 257629 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 50 total
  • MANE Select transcript: NM_145865

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26795
Approved symbolANKS4B
Nameankyrin repeat and sterile alpha motif domain containing 4B
Location16p12.2
Locus typegene with protein product
StatusApproved
AliasesFLJ38819, HARP
Ensembl geneENSG00000175311
Ensembl biotypeprotein_coding
OMIM609901
Entrez257629

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000311620

RefSeq mRNA: 1 — MANE Select: NM_145865 NM_145865

CCDS: CCDS42130

Canonical transcript exons

ENST00000311620 — 2 exons

ExonStartEnd
ENSE000011896122123369921233901
ENSE000012344622124973121253850

Expression profiles

Bgee: expression breadth broad, 44 present calls, max score 87.80.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6728 / max 140.5843, expressed in 80 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1531000.672880

Top tissues by expression

125 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499187.80gold quality
duodenumUBERON:000211486.54gold quality
rectumUBERON:000105284.09gold quality
liverUBERON:000210782.71gold quality
right lobe of liverUBERON:000111480.01gold quality
small intestineUBERON:000210875.61gold quality
small intestine Peyer’s patchUBERON:000345474.90gold quality
transverse colonUBERON:000115773.81gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047373.79silver quality
adult mammalian kidneyUBERON:000008273.74gold quality
gall bladderUBERON:000211070.11gold quality
colonic epitheliumUBERON:000039769.91gold quality
kidneyUBERON:000211369.00gold quality
intestineUBERON:000016065.20gold quality
islet of LangerhansUBERON:000000663.66gold quality
vermiform appendixUBERON:000115461.57gold quality
colonUBERON:000115560.64gold quality
cortex of kidneyUBERON:000122556.28gold quality
sural nerveUBERON:001548855.45gold quality
cerebellumUBERON:000203753.26gold quality
cerebellar cortexUBERON:000212953.24gold quality
cerebellar hemisphereUBERON:000224553.08gold quality
right hemisphere of cerebellumUBERON:001489052.40gold quality
smooth muscle tissueUBERON:000113551.66gold quality
pancreasUBERON:000126449.39gold quality
metanephros cortexUBERON:001053348.17gold quality
stomachUBERON:000094544.66gold quality
muscle tissueUBERON:000238543.62gold quality
body of stomachUBERON:000116143.50gold quality
mucosa of stomachUBERON:000119942.76silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.75

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): ESR1, HNF4A

miRNA regulators (miRDB)

68 targeting ANKS4B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-493-5P99.9672.472382
HSA-MIR-515-5P99.9269.822343
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-6817-3P99.7968.352126
HSA-MIR-4668-5P99.7970.583782
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-430699.7270.503630
HSA-MIR-149-3P99.7268.223963
HSA-MIR-6779-5P99.7065.762363
HSA-MIR-30B-3P99.7065.762325
HSA-MIR-3689A-3P99.7065.732306
HSA-MIR-3689B-3P99.7065.712311
HSA-MIR-3689C99.7065.712311
HSA-MIR-5580-3P99.7069.412052
HSA-MIR-6883-5P99.6968.053785
HSA-MIR-580-3P99.6769.231841
HSA-MIR-46699.6770.852863
HSA-MIR-613499.6365.681537
HSA-MIR-7152-5P99.6069.332094
HSA-MIR-885-5P99.5968.59879
HSA-MIR-4649-3P99.5666.901783

Literature-anchored findings (GeneRIF, showing 3)

  • ankyrin repeat and sterile alpha motif domain containing 4B (ANKS4B) localizes to the tips of adherent brush border microvilli and is essential for intermicrovillar adhesion (PMID:26812018)
  • Myosin VII, USH1C, and ANKS4B or USH1G Together Form Condensed Molecular Assembly via Liquid-Liquid Phase Separation. (PMID:31644917)
  • A cryptic sequence targets the adhesion complex scaffold ANKS4B to apical microvilli to promote enterocyte brush border assembly. (PMID:32636301)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioanks4bENSDARG00000036846
mus_musculusAnks4bENSMUSG00000030909
rattus_norvegicusAnks4bENSRNOG00000046181
drosophila_melanogasterSansFBGN0033785

Paralogs (1): USH1G (ENSG00000182040)

Protein

Protein identifiers

Ankyrin repeat and SAM domain-containing protein 4BQ8N8V4 (reviewed: Q8N8V4)

Alternative names: Harmonin-interacting ankyrin repeat-containing protein

All UniProt accessions (1): Q8N8V4

UniProt curated annotations — full annotation on UniProt →

Function. As part of the intermicrovillar adhesion complex/IMAC plays a role in epithelial brush border differentiation, controlling microvilli organization and length. Plays a role in assembly of the complex. May play a role in cellular response to endoplasmic reticulum stress.

Subunit / interactions. Part of the IMAC/intermicrovillar adhesion complex/intermicrovillar tip-link complex composed of ANKS4B, MYO7B, USH1C, CDHR2 and CDHR5. Interacts with USH1C; the interaction is direct and is required for ANKS4B localization to the tip of microvilli. Interacts with MYO7B; the interaction is direct. May interact with HSPA5.

Subcellular location. Cell projection. Microvillus.

Tissue specificity. Expressed in kidney and small intestine.

RefSeq proteins (1): NP_665872* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001660SAMDomain
IPR002110Ankyrin_rptRepeat
IPR013761SAM/pointed_sfHomologous_superfamily
IPR036770Ankyrin_rpt-contain_sfHomologous_superfamily
IPR037601ANKS4B_SAMDomain

Pfam: PF00536, PF12796

UniProt features (16 total): region of interest 4, repeat 3, compositionally biased region 2, mutagenesis site 2, chain 1, short sequence motif 1, modified residue 1, domain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N8V4-F170.570.42

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 283

Mutagenesis-validated functional residues (2):

PositionPhenotype
48decreased localization to microvilli.
417decreased interaction with ush1c.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 64 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOCC_APICAL_PART_OF_CELL, chr16p12, GOCC_MICROVILLUS, GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ACTIN_BASED_CELL_PROJECTION, GOCC_ORGANELLE_SUBCOMPARTMENT, GOCC_BRUSH_BORDER, BAKKER_FOXO3_TARGETS_DN, SERVITJA_ISLET_HNF1A_TARGETS_DN, GOBP_BRUSH_BORDER_ASSEMBLY, GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP, HHEX_TARGET_GENES

GO Biological Process (5): cell differentiation (GO:0030154), response to endoplasmic reticulum stress (GO:0034976), protein-containing complex assembly (GO:0065003), protein localization to microvillus (GO:1904106), brush border assembly (GO:1904970)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (6): endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), microvillus (GO:0005902), brush border (GO:0005903), cell projection (GO:0042995), plasma membrane bounded cell projection (GO:0120025)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular component assembly2
cellular developmental process1
cellular response to stress1
protein-containing complex organization1
protein localization to actin cytoskeleton1
binding1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
membrane1
cell periphery1
actin filament bundle1
actin-based cell projection1
microvillus1
apical part of cell1
cluster of actin-based cell projections1
cellular anatomical structure1
cell projection1
plasma membrane region1

Protein interactions and networks

STRING

996 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ANKS4BMYO7BQ6PIF6899
ANKS4BE9PNW1E9PNW1887
ANKS4BCDHR5Q9HBB8802
ANKS4BCDHR2Q9BYE9790
ANKS4BPLA2G12BQ9BX93539
ANKS4BABHD15Q6UXT9526
ANKS4BN4BP2L1Q5TBK1507
ANKS4BZNF732B4DXR9505
ANKS4BZSWIM3Q96MP5484
ANKS4BSLC35D1Q9NTN3434
ANKS4BCDH23Q9H251430
ANKS4BLDLRAD1Q5T700426
ANKS4BSLC7A14Q8TBB6406
ANKS4BTM4SF4P48230387
ANKS4BMYO7AP78427383

IntAct

12 interactions, top by confidence:

ABTypeScore
ANKS4BLRRK2psi-mi:“MI:0407”(direct interaction)0.620
LRRK2ANKS4Bpsi-mi:“MI:0407”(direct interaction)0.620
ANKS4BUSH1Cpsi-mi:“MI:0915”(physical association)0.560
ANKS4BMFHAS1psi-mi:“MI:0407”(direct interaction)0.440
ANKS4Bpsi-mi:“MI:0407”(direct interaction)0.440
ANKS4BPLECpsi-mi:“MI:0915”(physical association)0.400
ANKS4BMPP7psi-mi:“MI:0914”(association)0.350
ANKS4BUSH1Cpsi-mi:“MI:0915”(physical association)0.000

BioGRID (11): ANKS4B (Biochemical Activity), ANKS4B (Reconstituted Complex), ANKS4B (Reconstituted Complex), ANKS4B (Two-hybrid), ANKS4B (Proximity Label-MS), BANP (Affinity Capture-MS), USH1C (Affinity Capture-MS), MPP7 (Affinity Capture-MS), ANKS4B (Cross-Linking-MS (XL-MS)), ATP6V1E1 (Cross-Linking-MS (XL-MS)), APP (Reconstituted Complex)

ESM2 similar proteins: A0JPH7, A1A5Q0, B0R034, E1BTG2, E1C065, E1C760, F1MUG2, F7AEX0, G3XA57, O60308, P30306, P48966, Q02225, Q0IID7, Q0VBD2, Q14B46, Q28E45, Q28FA8, Q3UHZ5, Q4KM37, Q5EAW4, Q5FWH3, Q5JTW2, Q5RHY1, Q5XGX5, Q60949, Q6GQN0, Q6INA9, Q6NTY8, Q6NU40, Q6P5Q4, Q7L590, Q80U87, Q8BN58, Q8BXR9, Q8BZN6, Q8C5W4, Q8GT06, Q8K3X6, Q8N8V4

Diamond homologs: O94830, Q495M9, Q6NZC7, Q80T11, Q80Y98, Q80YA3, Q8K3X6, Q8N8V4, Q9Y6Y8, O14593, Q3KP44, Q8BLD6, Q9Z205, P0C0T2, Q24009, Q5M9H0, Q5U4T7, Q5XJ13, Q68DC2, Q6GQX6, Q6ZW76, Q99MQ1, Q9CZK6, Q9H694, Q9IA00, O00562, O35954, P43125, Q12204, Q3UHE1, Q5U2N3, Q6ZPQ6, Q9BZ71, Q9BZ72

SIGNOR signaling

1 interactions.

AEffectBMechanism
SMURF1unknownANKS4Bubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

50 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance42
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

197 predictions. Top by Δscore:

VariantEffectΔscore
16:21233898:GAGG:Gdonor_gain1.0000
16:21233900:GG:Gdonor_gain1.0000
16:21233901:GG:Gdonor_gain1.0000
16:21233902:G:GAdonor_loss1.0000
16:21233902:G:GGdonor_gain1.0000
16:21233903:T:TCdonor_loss1.0000
16:21249727:CTA:Cacceptor_loss1.0000
16:21249728:TA:Tacceptor_loss1.0000
16:21249729:A:AGacceptor_gain1.0000
16:21249729:AGAG:Aacceptor_gain1.0000
16:21249729:AGAGG:Aacceptor_gain1.0000
16:21249730:G:GGacceptor_gain1.0000
16:21249730:GA:Gacceptor_gain1.0000
16:21249730:GAGG:Gacceptor_gain1.0000
16:21249730:GAGGG:Gacceptor_gain1.0000
16:21233899:AGG:Adonor_gain0.9900
16:21233900:GGG:Gdonor_gain0.9900
16:21237577:G:GTdonor_gain0.9900
16:21237582:G:Tdonor_gain0.9900
16:21249728:TAGAG:Tacceptor_gain0.9900
16:21249727:CTAGA:Cacceptor_gain0.9800
16:21233899:AGGGT:Adonor_gain0.9700
16:21233900:GGGT:Gdonor_gain0.9700
16:21233901:GGT:Gdonor_gain0.9700
16:21233902:GT:Gdonor_gain0.9700
16:21234166:G:Tdonor_gain0.9700
16:21237586:G:GTdonor_gain0.9700
16:21249726:TCTAG:Tacceptor_gain0.9700
16:21249727:CTAG:Cacceptor_gain0.9700
16:21249728:TAG:Tacceptor_gain0.9700

AlphaMissense

2773 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:21233841:C:AP35H0.996
16:21233763:C:AA9D0.995
16:21250711:T:CL382P0.993
16:21233841:C:GP35R0.992
16:21233856:C:AA40D0.992
16:21249784:C:AA73D0.992
16:21249880:C:AA105D0.992
16:21233880:T:CL48P0.991
16:21249751:A:TD62V0.991
16:21249781:C:AA72E0.991
16:21249760:G:TG65V0.989
16:21233787:T:CL17P0.988
16:21233853:C:AA39E0.988
16:21249783:G:CA73P0.988
16:21249769:C:GP68R0.987
16:21249808:T:AV81D0.987
16:21249817:T:CL84P0.987
16:21233795:G:CA20P0.986
16:21233852:G:CA39P0.986
16:21233855:G:CA40P0.986
16:21233865:G:TG43V0.986
16:21233796:C:AA20D0.985
16:21233864:G:TG43W0.985
16:21249916:T:CL117P0.985
16:21249769:C:AP68H0.984
16:21249772:T:CL69P0.984
16:21249879:G:CA105P0.983
16:21249751:A:CD62A0.982
16:21249752:C:AD62E0.982
16:21249752:C:GD62E0.982

dbSNP variants (sampled 300 via entrez): RS1000115582 (16:21249582 G>A), RS1000584447 (16:21235720 C>G), RS1000873649 (16:21236966 T>C), RS1000928051 (16:21248286 G>A,C,T), RS1000928439 (16:21242355 T>C), RS1000959339 (16:21248622 C>T), RS1001519679 (16:21244199 T>C), RS1001550812 (16:21242859 A>C), RS1001671435 (16:21250690 T>C), RS1001707997 (16:21237082 G>A), RS1001997361 (16:21241760 T>C), RS1002065181 (16:21243236 A>C,G), RS1002141285 (16:21238494 TATAC>T), RS1002284303 (16:21241549 T>A), RS1002451483 (16:21247541 G>A)

Disease associations

OMIM: gene MIM:609901 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST003226_4Pelvic organ prolapse4.000000e-07

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression, decreases expression2
Acetaminophenincreases expression, decreases expression2
Benzo(a)pyreneaffects methylation, decreases expression, increases methylation2
Cyclosporinedecreases expression2
Aflatoxin B1affects expression, decreases expression, decreases methylation2
propionaldehydedecreases expression1
beta-lapachonedecreases expression1
butyraldehydedecreases expression1
pentanaldecreases expression1
CGP 52608affects binding, increases reaction1
abrinedecreases expression1
(+)-JQ1 compounddecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Air Pollutantsdecreases expression1
Aldehydesdecreases expression1
Cisplatinincreases expression1
Dimethyl Sulfoxideincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Quercetindecreases expression1
Silicon Dioxidedecreases expression1
Silverdecreases expression1
Urethanedecreases expression1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pelvic organ prolapse